Santhera Obtains European Patent for Use of Catena®/Sovrima® in the Treatment of Muscular Dystrophies -- more

Trubion Pharmaceuticals Announces Agreement to be Acquired by Emergent BioSolutions -- more

Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma -- more

Dicerna Closes $25 Million Series B Financing -- more

Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry -- more

GE Capital Provides $5 Million Credit Facility To Mitralign, Inc. -- more

VaxInnate: Two Start-Ups Aim To Change Economics Of Vaccine Production -- more

Fairfield County resident, Cornelius T. Ryan, named one of the “Irish Life Science 50” -- more

MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program -- more

Gilead Sciences to Acquire CGI Pharmaceuticals for Up to $120 Million -- more

Santhera's Catena® Improved Vision in Patients with Leber's Hereditary Optic Neuropathy; Regulatory Submissions Planned in First Half of 2011 --
Archived News Items